0001385508-22-000012.txt : 20220105
0001385508-22-000012.hdr.sgml : 20220105
20220105162126
ACCESSION NUMBER: 0001385508-22-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220104
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Toole David D
CENTRAL INDEX KEY: 0001491140
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38193
FILM NUMBER: 22511426
MAIL ADDRESS:
STREET 1: 1640 MARENGO STREET
CITY: LOS ANGELES
STATE: CA
ZIP: 90033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001385508
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 233 WILSHIRE BLVD, SUITE 280
STREET 2: SUITE 500
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
BUSINESS PHONE: (310) 598-5410
MAIL ADDRESS:
STREET 1: 233 WILSHIRE BLVD, SUITE 280
STREET 2: SUITE 500
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
FORMER COMPANY:
FORMER CONFORMED NAME: Lightlake Therapeutics Inc.
DATE OF NAME CHANGE: 20091009
FORMER COMPANY:
FORMER CONFORMED NAME: Madrona Ventures, Inc.
DATE OF NAME CHANGE: 20070108
4
1
wf-form4_164141760647083.xml
FORM 4
X0306
4
2022-01-04
0
0001385508
OPIANT PHARMACEUTICALS, INC.
OPNT
0001491140
O'Toole David D
C/O OPIANT PHARMACEUTICALS, INC.
233 WILSHIRE BOULEVARD, SUITE 280
SANTA MONICA
CA
90401
0
1
0
0
Chief Financial Officer
Common Stock
2022-01-04
4
A
0
12000
0
A
36015
D
12,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-third of the RSUs vest on the anniversary dates of January 4, 2023, January 4, 2024 and January 4, 2025, subject to the Reporting Person continuing as a service provider through each such date.
/s/ David D. O'Toole
2022-01-05